Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Nature Genetics (Impact Factor: 29.65). 12/2004; 36(11):1213-8. DOI: 10.1038/ng1453
Source: PubMed

ABSTRACT Osteopoikilosis, Buschke-Ollendorff syndrome (BOS) and melorheostosis are disorders characterized by increased bone density. The occurrence of one or more of these phenotypes in the same individual or family suggests that these entities might be allelic. We collected data from three families in which affected individuals had osteopoikilosis with or without manifestations of BOS or melorheostosis. A genome-wide linkage analysis in these families, followed by the identification of a microdeletion in an unrelated individual with these diseases, allowed us to map the gene that is mutated in osteopoikilosis. All the affected individuals that we investigated were heterozygous with respect to a loss-of-function mutation in LEMD3 (also called MAN1), which encodes an inner nuclear membrane protein. A somatic mutation in the second allele of LEMD3 could not be identified in fibroblasts from affected skin of an individual with BOS and an individual with melorheostosis. XMAN1, the Xenopus laevis ortholog, antagonizes BMP signaling during embryogenesis. In this study, LEMD3 interacted with BMP and activin-TGFbeta receptor-activated Smads and antagonized both signaling pathways in human cells.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Melorheostosis is a rare entity belonging to the group of sclerotic bone dysplasias. Described for the first time in 1922 by Leri, it remains imperfectly known as clinical presentations are highly variable, and the etiological diagnosis is not fully elucidated. We report a case of polyostoticmelorheostosis for which radiological investigations were complete, in order to study this disease.
    The Pan African medical journal. 01/2014; 18:251.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A rare disease alicts less than 200,000 individuals, according to the National Organization for Rare Diseases (NORD) of the United States. Over 6,000 rare disorders afect approximately 1 in 10 Americans. Rare genetic bone disorders remain the major causes of disability in US patients. hese rare bone disorders also represent a therapeutic challenge for clinicians, due to lack of understanding of underlying mechanisms. his systematic review explored current literature on therapeutic directions for the following rare genetic bone disorders: ibrous dysplasia, Gorham-Stout syndrome, ibrodysplasia ossiicans progressiva, melorheostosis, multiple hereditary exostosis, osteogenesis imperfecta, craniometaphyseal dysplasia, achondroplasia, and hypophosphatasia. he disease mechanisms of Gorham-Stout disease, melorheostosis, and multiple hereditary exostosis are not fully elucidated. Inhibitors of the ACVR1/ALK2 pathway may serve as possible therapeutic intervention for FOP. he use of bisphosphonates and IL-6 inhibitors has been explored to be useful in the treatment of ibrous dysplasia, but more research is warranted. Cell therapy, bisphosphonate polytherapy, and human growth hormone may avert the pathology in osteogenesis imperfecta, but further studies are needed. here are still no current efective treatments for these bone disorders; however, signiicant promising advances in therapeutic modalities were developed that will limit patient sufering and treat their skeletal disabilities.
    BioMed Research International 10/2014; 2014(670842). · 2.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of traumatic humeral neck fracture occurring in a patient with osteopoikilosis after a motorcycle accident. The radiograph revealed the fracture but also multiple bone lesions. A few years before, the patient had been operated for a maldiagnosed chondrosarcoma of the humeral head. Osteopoikilosis is a rare benign hereditary bone disease, whose mode of inheritance is autosomal dominant. It is usually asymptomatic and discovered incidentally on radiograph that shows the presence of multiple osteoblastic lesions. It can mimic other bone pathologies, in particular osteoblastic metastases. Osteopoikilosis is a diagnosis that should be kept in mind to avoid misdiagnosis, particularly with regard to cancer metastasis. This disorder does not require any treatment and complications are rare. However, there may be associated anomalies that require follow-up.
    Case reports in orthopedics. 01/2014; 2014:520651.

Full-text (2 Sources)

Available from
May 29, 2014